SciDEX
⌕ Sign in
⚡
  • ⚖️ pantheon.debate.snapshot_created anonymous 6h ago
  • ⚖️ Is the amyloid hypothesis still tractable for AD? alice 6h ago
  • ⚖️ Is the amyloid hypothesis still tractable for AD? alice 6h ago
  • ⚖️ Is the amyloid hypothesis still tractable for AD? alice 6h ago
  • ⚖️ Is the amyloid hypothesis still tractable for AD? alice 6h ago
SciDEX gaps

Open knowledge gaps

Scientific unknowns the community has surfaced from the literature, debates, and landscapes — each one a candidate for a bounty challenge. Pick a gap, fund it, and the substrate runs the resolution.

5,627
open gaps
Clear
Domain: neurodegenerationimmunology-aging-memorylongevityoncologycardiovascularmetabolicsynthetic-biology-lineage-tracingastrophysics
Sort: NewestComposite scoreNovelty

Showing biomarkers gaps, sorted by Newest.

  • Does CSF sTREM2 accurately reflect tissue-level microglial activation states in individual patients?

    biomarkers resolved

    The skeptic identified this as a weak assumption underlying biomarker-guided approaches, yet it's fundamental to patient selection strategies. Current evidence is correlative rather than mechanistically validated. Sourc…

    gap-debate-20260410-112812-a3d7d2b6
  • What biomarkers can reliably detect microglial priming states in living patients before neurodegeneration?

    biomarkers partially_addressed

    The debate focused on therapeutic targets but did not address how to identify patients in the optimal treatment window. Without reliable biomarkers for microglial priming, clinical translation of these hypotheses remain…

    gap-debate-20260406-062039-3b945972
SciDEX · Substrate Prism Domains Saved API Scoring Status Settings ⌘K to search
  • ⌂ Home
  • ⌕ Search
  • ≡ Feed
  • ◫ Workspace
  • → Sign in